
SEELQ
Healthcare · Biotechnology · $5 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 14, 2024 | Time not confirmed | -0.05 | 1.98 | +4060.0% |
| Apr 26, 2024 | Time not confirmed | — | -26.21 | — |
| Mar 1, 2024 | Time not confirmed | -0.06 | -71.26 | -111421.4% |
| Nov 14, 2023 | After the close | -307.20 | -326.78 | -6.4% |
| Aug 11, 2023 | After the close | -345.60 | -316.80 | +8.3% |
| May 12, 2023 | After the close | -422.40 | -449.66 | -6.5% |
| Mar 3, 2023 | Time not confirmed | -0.17 | -5.10 | -2946.6% |
| Nov 10, 2022 | After the close | -403.20 | -691.20 | -71.4% |
| Aug 5, 2022 | After the close | -595.20 | -768.00 | -29.0% |
| May 10, 2022 | After the close | -614.40 | -499.20 | +18.8% |
| Mar 4, 2022 | Time not confirmed | -0.25 | -7.80 | -2979.4% |
| Nov 5, 2021 | After the close | -355.20 | -422.40 | -18.9% |
| Aug 6, 2021 | After the close |
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene…
| -518.40 |
| -288.77 |
| +44.3% |
| Apr 30, 2021 | After the close | -364.80 | -1075.20 | -194.7% |
| Mar 5, 2021 | Time not confirmed | -0.08 | -3.60 | -4400.0% |
| Nov 12, 2020 | After the close | -307.20 | -345.60 | -12.5% |
| Aug 14, 2020 | Before the open | -518.40 | -307.20 | +40.7% |
| May 7, 2020 | After the close | -844.80 | -537.60 | +36.4% |
| Mar 18, 2020 | Time not confirmed | -0.39 | -13.65 | -3400.0% |
| Nov 7, 2019 | After the close | -460.80 | -577.92 | -25.4% |
| Aug 1, 2019 | Before the open | -576.00 | -617.09 | -7.1% |
| May 6, 2019 | Time not confirmed | -0.18 | -62.70 | -34733.3% |
| Mar 25, 2019 | Time not confirmed | -4.20 | -73.20 | -1642.9% |
| Oct 31, 2018 | Time not confirmed | -0.14 | -108.00 | -77042.9% |
| Aug 9, 2018 | Time not confirmed | -0.14 | -90.00 | -64185.7% |
| May 3, 2018 | Time not confirmed | -0.14 | -126.00 | -89900.0% |
| Mar 1, 2018 | Time not confirmed | -0.14 | -0.16 | -14.3% |